-
1
-
-
57649101120
-
Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer
-
Muggia F. Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol. Oncol. 2009, 112:275-281.
-
(2009)
Gynecol. Oncol.
, vol.112
, pp. 275-281
-
-
Muggia, F.1
-
2
-
-
77951658572
-
A better platinum-based anticancer drug yet to come?
-
Olszewski U., Hamilton G. A better platinum-based anticancer drug yet to come?. Anticancer Agents Med. Chem. 2010, 10:293-301.
-
(2010)
Anticancer Agents Med. Chem.
, vol.10
, pp. 293-301
-
-
Olszewski, U.1
Hamilton, G.2
-
3
-
-
13444257970
-
Physical and chemical stability of palonosetron HCl with cisplatin carboplatin, and oxaliplatin during simulated Y-site administration
-
Trissel L.A., Zhang Y. Physical and chemical stability of palonosetron HCl with cisplatin carboplatin, and oxaliplatin during simulated Y-site administration. J. Oncol. Pharm. Pract. 2004, 10:191-195.
-
(2004)
J. Oncol. Pharm. Pract.
, vol.10
, pp. 191-195
-
-
Trissel, L.A.1
Zhang, Y.2
-
4
-
-
0030977824
-
Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperature
-
Schuldes H., Bade S., Knobloch J., Jonas D. Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperature. Cancer 1997, 79:1723-1728.
-
(1997)
Cancer
, vol.79
, pp. 1723-1728
-
-
Schuldes, H.1
Bade, S.2
Knobloch, J.3
Jonas, D.4
-
6
-
-
0033437646
-
Investigations on the stability of carboplatin infusion solutions
-
Gust R., Schnurr B. Investigations on the stability of carboplatin infusion solutions. Monatsh. Chem. 1999, 130:637-644.
-
(1999)
Monatsh. Chem.
, vol.130
, pp. 637-644
-
-
Gust, R.1
Schnurr, B.2
-
7
-
-
60349100582
-
Stability of oxaliplatin solution
-
Junker A., Roy S., Desroches M.C., Moussay C., Berhoune M., Bellanger A., Fernandez C., Farinotti R. Stability of oxaliplatin solution. Ann. Pharmacother. 2009, 43:390-391.
-
(2009)
Ann. Pharmacother.
, vol.43
, pp. 390-391
-
-
Junker, A.1
Roy, S.2
Desroches, M.C.3
Moussay, C.4
Berhoune, M.5
Bellanger, A.6
Fernandez, C.7
Farinotti, R.8
-
8
-
-
0023111825
-
Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues
-
Behrens B.C., Hamilton T.C., Masuda H., Grotzinger K.R., Whang-Peng J., Louie K.G., Knutsen T., McKoy W.M., Young R.C., Ozols R.F. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 1987, 47:414-418.
-
(1987)
Cancer Res.
, vol.47
, pp. 414-418
-
-
Behrens, B.C.1
Hamilton, T.C.2
Masuda, H.3
Grotzinger, K.R.4
Whang-Peng, J.5
Louie, K.G.6
Knutsen, T.7
McKoy, W.M.8
Young, R.C.9
Ozols, R.F.10
-
9
-
-
79952122944
-
Cell death assays for drug discovery
-
Kepp O., Galluzzi L., Lipinski M., Yuan J., Kroemer G. Cell death assays for drug discovery. Nat. Rev. Drug Discov. 2011, 10:221-237.
-
(2011)
Nat. Rev. Drug Discov.
, vol.10
, pp. 221-237
-
-
Kepp, O.1
Galluzzi, L.2
Lipinski, M.3
Yuan, J.4
Kroemer, G.5
|